[{"Assets_0_Q2_USD":113509000.0,"CommonStockSharesOutstanding_0_Q2_shares":80428000.0,"NetIncomeLoss_2_Q2_USD":-31105000.0,"NetIncomeLoss_1_Q2_USD":-16886000.0,"StockholdersEquity_0_Q2_USD":24076000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":80418000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":77807000.0,"Ticker":"BCRX","CIK":"882796","name":"BIOCRYST PHARMACEUTICALS INC","OfficialName":"BioCryst Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1887243586.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20170808"}]